Work

AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice

Year: 2011

Type: article

Source: Psychopharmacology

DOI: 10.1007/s00213-011-2491-1

Authors: Torbjörn U. C. Järbe, Sherrica Tai, Brian J. LeMay, Spyros P. Nikas, Vidyanand G. Shukla, Alexander Zvonok, Alexandros Makriyannis

Institution: Northeastern University

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, U.S. Public Health Service, National Institute on Drug Abuse

Awards: G1619951381, G196067886, G1966571441, Cannabinergic Ligands and Drugs, Molecular Basis of Cannabinoid Activity, Cannabinergic Medications for Methamphetamine Addiction, G341407372, MOLECULAR BASIS OF CANNABINOID ACITIVITY, Endogenous/exogenous cannabinoids: A comparison, Endocannabinoid Active Sites as Therapeutic Targets, G950272058

OpenAlex ID: W2017869956

FWCI: 2.81

Cites: 48

Cited by: 31

Related to: 10